- Home
- HUBC vs ESLA Comparison
HUBC vs ESLA Comparison
Compare HUBC & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- ESLA
- Stock Information
- Founded
- HUBC 2017
- ESLA 2021
- Country
- HUBC Israel
- ESLA United States
- Employees
- HUBC N/A
- ESLA N/A
- Industry
- HUBC
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUBC
- ESLA Health Care
- Exchange
- HUBC Nasdaq
- ESLA Nasdaq
- Market Cap
- HUBC 35.2M
- ESLA 35.5M
- IPO Year
- HUBC N/A
- ESLA N/A
- Fundamental
- Price
- HUBC $2.80
- ESLA $0.82
- Analyst Decision
- HUBC
- ESLA Strong Buy
- Analyst Count
- HUBC 0
- ESLA 1
- Target Price
- HUBC N/A
- ESLA $16.00
- AVG Volume (30 Days)
- HUBC 1.1M
- ESLA 18.2K
- Earning Date
- HUBC 05-01-2025
- ESLA 08-20-2025
- Dividend Yield
- HUBC N/A
- ESLA N/A
- EPS Growth
- HUBC N/A
- ESLA N/A
- EPS
- HUBC N/A
- ESLA N/A
- Revenue
- HUBC $29,562,000.00
- ESLA N/A
- Revenue This Year
- HUBC N/A
- ESLA N/A
- Revenue Next Year
- HUBC N/A
- ESLA N/A
- P/E Ratio
- HUBC N/A
- ESLA N/A
- Revenue Growth
- HUBC N/A
- ESLA N/A
- 52 Week Low
- HUBC $1.72
- ESLA $0.63
- 52 Week High
- HUBC $14.00
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- HUBC 46.20
- ESLA 42.20
- Support Level
- HUBC $2.32
- ESLA $0.82
- Resistance Level
- HUBC $4.33
- ESLA $0.95
- Average True Range (ATR)
- HUBC 0.46
- ESLA 0.06
- MACD
- HUBC -0.19
- ESLA -0.00
- Stochastic Oscillator
- HUBC 30.07
- ESLA 23.49
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.